Skip to content


  • Erratum
  • Open Access

Erratum to: COG5-CDG: expanding the clinical spectrum

  • 1, 2,
  • 1,
  • 1,
  • 2,
  • 3,
  • 4,
  • 5,
  • 6,
  • 7,
  • 7,
  • 1 and
  • 2Email author
Orphanet Journal of Rare Diseases20138:120

  • Received: 5 August 2013
  • Accepted: 5 August 2013
  • Published:

The original article was published in Orphanet Journal of Rare Diseases 2012 7:94


After the publication of this work [1] it was brought to the authors attention that the appropriate ethical approval and patient consent was not stated in the manuscript. We regret any inconvenience that this may have caused. The correct statement is given below:

Following approval from the institutional ethics committee, the family of all patients in this study provided written consent to participate in this study, along with consent to publish their clinical details and photographs.


Authors’ Affiliations

Centre for Human Genetics, University of Leuven, Leuven, Belgium
Centre for Metabolic Diseases, University Hospital Gasthuisberg, Herestraat 49, BE-3000 Leuven, Belgium
University Children’s Hospital Queen Fabiola, Brussels, Belgium
Division of Metabolism, Bambino Gesù Hospital, Rome, Italy
Duchess of Kent Children’s Hospital, University of Hong Kong, Pokfulam, Hong Kong
Institute of Chemistry and Technology of Polymers, Catania, Sicily, Italy
Structural and Functional Glycobiology Unit, University of Lille 1, Lille 1, France


  1. Rymen , et al: COG5-CDG: expanding the clinical spectrum. Orphanet J Rare Dis. 2012, 7: 94-10.1186/1750-1172-7-94.PubMed CentralPubMedView ArticleGoogle Scholar


© Rymen et al.; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.